Magnetic Resonance Imaging Evaluation of Bone Metastases Treated with Radiotherapy in Palliative Intent: A Multicenter Prospective Study on Clinical and Instrumental Evaluation Assessment Concordance (MARTE Study)
Authors:
- Alfonso ReginelliARAlfonso Reginelli
- Vittorio PatanèVPVittorio Patanè
- Fabrizio UrraroFUFabrizio Urraro
- Anna RussoARAnna Russo
- Marco De ChiaraMCMarco De Chiara
- Alfredo ClementeACAlfredo Clemente
- Umberto AtripaldiUAUmberto Atripaldi
- Giovanni BalestrucciGBGiovanni Balestrucci
- Mauro BuonoMBMauro Buono
- Emma D’ippolitoEDEmma D’ippolito
- Roberta GrassiRGRoberta Grassi
- Ida D’onofrioIDIda D’onofrio
Open Access
- 10 July 2023
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 13 (14) , 2334
Abstract
Metastasis to bone is a common occurrence among epithelial tumors, with a high incidence rate in the Western world. As a result, bone lesions are a significant burden on the healthcare system, with a high morbidity index. These injuries are often symptomatic and can lead to functional limitations, which in turn cause reduced mobility in patients. Additionally, they can lead to secondary complications such as pathological fractures, spinal cord compression, hypercalcemia, or bone marrow suppression. The treatment of bone metastases requires collaboration between multiple healthcare professionals, including oncologists, orthopedists, neurosurgeons, physiatrists, and radiotherapists. The primary objective of this study is to evaluate the correlation between two methods used to assess local control. Specifically, the study aims to determine if a reduction in the volume of bone lesions corresponds to better symptomatic control in the clinical management of patients, and vice versa. To achieve this objective, the study evaluates morphological criteria by comparing pre- and post-radiotherapy treatment imaging using MRI and RECIST 1.1 criteria. MRI without contrast is the preferred diagnostic imaging method, due to its excellent tolerance by patients, the absence of exposure to ionizing radiation, and the avoidance of paramagnetic contrast media side effects. This imaging modality allows for accurate assessment of bone lesions. One of the secondary objectives of this study is to identify potentially useful parameters that can distinguish patients into two classes: “good” and “poor” responders to treatment, as reported by previous studies in the literature. These parameters can be evaluated from the imaging examinations by analyzing morphological changes and radiomic features on different sequences, such as T1, STIR (short tau inversion recovery), and DWI-MRI (diffusion-weighted).Keywords
This publication has 43 references indexed in Scilit:
- Prevention and Treatment of Bone Metastases in Breast CancerJournal of Clinical Medicine, 2013
- Mri and Neurological Findings in Patients with Spinal MetastasesActa Radiologica, 2012
- SEOM guidelines for the treatment of bone metastases from solid tumoursClinical and Translational Oncology, 2012
- Palliative Radiotherapy for Bone Metastases: An ASTRO Evidence-Based GuidelineInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Transcriptional Control of SkeletogenesisAnnual Review of Genomics and Human Genetics, 2008
- Metastatic Spinal Lesions: State-of-the-Art Treatment Options and Future TrendsAmerican Journal of Neuroradiology, 2008
- Local Control of Regional and Metastatic Lesions and Indication for Systemic Chemotherapy in Patients with Non-Small Cell Lung CancerThe Oncologist, 2008
- Palliative Radiotherapy Trials for Bone Metastases: A Systematic ReviewJournal of Clinical Oncology, 2007
- Early marrow transplantation in a pre-symptomatic neonate with late infantile metachromatic leukodystrophy does not halt disease progressionBone Marrow Transplantation, 2007
- The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancerAnnals of Oncology, 2005